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Someday—and some say it will be soon—we will all wake
up to a headline that reads ‘‘New life created in the lab.’’
This new life will metabolize, reproduce, and evolve. It
will be more than a recombinant modiﬁcation of an exist-
ing cell. It may be a new life form created ‘‘from the bottom
up,’’ from modular BioBrick components, or perhaps a
modiﬁcation of existing life that is so radically different—
a wholly new embedded genome, with a minimalist but
differentmetabolism—that its proponentswill feel justiﬁed
in calling it new. There will be questions about whether it
really is ‘‘alive’’ and how it was created, and then there
will be a stream of comments, negative and positive,
ranging from the newly proven techniques’ potential for
good to their extraordinary, if unknown, dangers, and
some will ask whether scientists are wrong to be ‘‘playing
God.’’ There will be calls for regulation, but by whom,
with what tools, and to what end will be open for debate.
Someone will mention a moratorium. Someone else will
mention bioterrorism. To some, this will be dawn of a
new era, in which the insights of genetics, combined with
the practiced facility of engineering, have empowered
geneticists to create profound new organismic applications
for great good. They will have reachable applications in
mind, for biofuels or tumor-targeting cells. Others will say
that this is the day that we ﬁnally begin to achieve our
doom, through acquiring a power so terribly beyond our
wisdom to control that it will overtake us.
Some of these ideas are captured and addressed in ‘‘The
Ethics of Protocells—The Moral and Social Implications
of Creating Life in the Laboratory.’’ The aim of this upbeat
edition is to prepare us for that day in a way that we have
seldom been prepared for previous radically new scientiﬁc
advances. The book contains several concise, nonhyped
expositions of the scientiﬁc developments, with references
that lead easily into web-based and other resources for
understanding the surprisingly extensive ongoing scien-140 The American Journal of Human Genetics 85, 140–141, Augusttiﬁc work. There are anthropological and bioethical pieces
of unusual focus, from grand masters of the profession,
such as Laurie Zoloth, to relative newcomers, such as a dis-
sertant who spent thesis years mulling over reconciling
contradictions in the so-called ‘‘precautionary rule.’’ Risk,
fear, uncertainty, precaution, and how to address these
issues ethically and publicly are the key themes. Additional
themes include lessons from the old technologies and their
use in understanding the new technologies, as well as
predictable complications, such as intellectual property
claims to life. A recurrent feature of the work, unheralded
by the editors but nicely present, is, ﬁrst, to address
a subject directly and concretely (such as speciﬁc risks of
protocells and risk-management approaches) and, second,
to meta-question the underlying methods (e.g., ‘‘Why is
a precautionary approach to risks of new science right or
wrong? How do we assess risk generally, and are there
ways to do it better?’’).
This feature leads to an edition of unusual depth, with
implications for science policy and bioethics. It also
means that the progressiveness of the science is matched
by recurrent willingness to query the typical norms of
ethical and social connection. The reader will not ﬁnd,
in this edition, a principalist examination of protocell
bioethics under classic or conventional frameworks. But
the reader will ﬁnd, for example, a challenge to bioethics
itself, to move from ‘‘Mode 1,’’ specialty expertise, to
‘‘Mode 2,’’ engagement regarding how the public, scien-
tists, and society should engage in creating process rules
that will help science and other human values to ﬂourish
together. Similarly, one will ﬁnd no articles mapping out
exclusive patenting strategies to encourage venture capital
support; but one will ﬁnd two articles exploring the bene-
ﬁts of adapting open-source thinking. There is a zesty
engagement with the future, in which the optimism of
the scientists seems to have carried over into a progressive
approach to the social and ethical problems, as well as
a conviction that if these problems are frankly stated,
they can be imaginatively resolved. It is as if by breathing
new life into science, new forms of life appear for bioethics
as well.
The editors rightly note that this book is the beginning
of discussion, not the end of it. Volume 2—and one wants
a Volume 2—would include some science- and technology-
studies scholars, who could look at assumptions, policy
development, and politics, as well as some legal and social
engineers, such as those who have helped to develop
self-regulatory guidelines and could frame alternative*Correspondence: patrick.taylor@childrens.harvard.edu
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approaches with effective public engagement; and, for bal-
ance, some pessimists, who would challenge the optimists
to continue to bring out their best work. It would also
include some cross-talk among the different schools of pro-
tocell development, to clarify the extent to which their
methodological debates have distinct social and ethical
implications.
Both the book and the subject have multidisciplinary
breadth. Thus, for any reader of a given background, an
article or two will probably be uphill reading. Those who
have pet theories, approaches, schools of thought, and
factions may well ﬁnd them absent from this book; if their
measure of a book is whether they see their own views
reﬂected, they are likely to be disappointed, because this
book is neither an anthology nor a comprehensive treat-The Amerment in such a sense. It is a new book, with new ideas,
andmust be read on its own terms.Whether one is a genet-
icist wondering about new developments or a general
reader interested in expanding horizons for ethics in
science policy, there is much to learn from this engaging
and prescient collection. It may not be until Volume 2,
or even Volume 5, that we are all truly prepared for the
day of the headline ‘‘New life created in the lab.’’ But
Volume 1 sets us well on our way and, most importantly,
begins a thoughtful conversation of general importance
that cannot have begun too soon.
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